Google data could improve forecasting of influenza levels

http://m.medicalxpress.com/news/2014-10-google-influenza.html

Posted by Rob LW

U.S. FDA Grants Fast Track Designation to Novavax' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM) Nasdaq:NVAX

https://globenewswire.com/news-release/2014/10/29/677901/10105274/en/U-S-FDA-Grants-Fast-Track-Designation-to-Novavax-H7N9-Influenza-Virus-Like-Particle-Vaccine-Candidate-Adjuvanted-With-Matrix-M-TM.html


Posted by Rob LW

Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia on Sunday, October 26 Nasdaq:NVAX

https://globenewswire.com/news-release/2014/10/26/676503/10104462/en/Novavax-Presents-RSV-F-Protein-Nanoparticle-Vaccine-Clinical-Data-at-the-8th-Vaccine-ISV-Congress-in-Philadelphia-on-Sunday-October-26.html

Posted by Rob LW

Australia's CSL buys Novartis influenza vaccine unit for $275 million

http://mobile.reuters.com/article/idUSKBN0IF0Z720141026?irpc=932


Posted by Rob LW

Throwback Thursday | The 1918 Influenza Pandemic - New York Times (blog)

Throwback Thursday | The 1918 Influenza Pandemic - New York Times (blog)
INFLUENZA - GOOGLE NEWS | 16 OCTOBER 2014
http://pulse.me/s/2UcND8


New York Times (blog)Throwback Thursday | The 1918 Influenza PandemicNew York Times (blog)As scientists confront the Ebola ... Read more
Posted by Rob LW
--

Vaxart's Tablet Vaccine for H1N1 Influenza Generates Protective Immunity ... - FierceVaccines

Vaxart's Tablet Vaccine for H1N1 Influenza Generates Protective Immunity ... - FierceVaccines
INFLUENZA - GOOGLE NEWS | 16 OCTOBER 2014
http://pulse.me/s/2SOcql
Vaxart's Tablet Vaccine for H1N1 Influenza Generates Protective Immunity ...FierceVaccinesThe data were generated in a ... Read more

Posted by Rob LW

LONDON: Mucosis Presents Data on Intranasal RSV Vaccine SynGEM® at Vaccines 2014 Conference | Business Wire | Rock Hill Herald Online

http://www.heraldonline.com/2014/10/20/6436272/mucosis-presents-data-on-intranasal.html?sp=/100/773/385/


Posted by Rob LW

Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects - MarketWatch

http://www.marketwatch.com/story/novavax-initiates-phase-2-clinical-trial-of-rsv-vaccine-in-elderly-subjects-2014-10-14-81953623

Posted by Rob LW

'Virological penicillin': Plant MIR2911 directly targets influenza A viruses

http://medicalxpress.com/news/2014-10-virological-penicillin-mir2911-influenza-viruses.html

It's a shame how this has been reported, but the fundamental science looks really interesting, early days though.

Posted by Rob LW

Influenza researcher Yoshihiro Kawaoka wins Breakthrough Award

http://www.news.wisc.edu/23184

What a well-deserved award, amazing contribution to the flu world and a very wonderful guy.

Solving the mystery of why colds cause asthma attacks - Medical News Today

http://www.medicalnewstoday.com/articles/283337.php

Older Folks and Influenza: High Dose Vaccine 24% More Effective

http://www.hcplive.com/publications/internal-medicine-world-report/2014/September-2014/Older-Folks-and-Influenza-High-Dose-Vaccine-24-More-Effective


Thanks


Rob

This email was sent from a mobile device with an annoyingly small keyboard, apologies for any typos

Visterra bringing influenza immunotherapy into Phase 2 with $30M cash influx

http://medcitynews.com/2014/10/visterra-bringing-influenza-immunotherapy-phase-2-30m-cash-influx/


Thanks


Rob

This email was sent from a mobile device with an annoyingly small keyboard, apologies for any typos

J and J purchase Alios

http://www.jnj.com/news/all/Johnson-Johnson-Announces-Agreement-To-Acquire-Alios-BioPharma